# Outlook Therapeutics, Inc.: filings

OTLK · Nasdaq · CIK 1649989 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/otlk.md) · [Financials](/companies/otlk/financials.md) · [Filings](/companies/otlk/filings.md) · [Insiders](/companies/otlk/insiders.md)

## Reports and events: 284 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 266, 8-K 176, 10-Q 32, 3 32, 424B3 32, CORRESP 28, SC 13D/A 23, EFFECT 22, 424B5 21, UPLOAD 19, D 13, DEF 14A 13, S-8 12, S-3 11, SC 13G 11, SC 13G/A 11, 10-K 10, PRE 14A 9, S-1/A 9, SCHEDULE 13G/A 9, 10-K/A 6, DEFA14A 6, POS AM 6, S-1 6, 4/A 5, SCHEDULE 13D/A 5, SCHEDULE 13G 5, ARS 4, FWP 4, 25-NSE 3, SC 13D 3, 3/A 2, 424B4 2, CERTNAS 2, CT ORDER 2, DRS 2, DRS/A 2, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, DRSLTR 1, NT 10-Q 1, POS EX 1, PRER14A 1, S-1MEF 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 20:30 ET | [8-K](/filings/0001104659-26-112356.md) | 3.01 Delisting notice | 0001104659-26-112356 |
| 2026-09-18 | 20:30 ET | [8-K](/filings/0001104659-26-108952.md) | 8.01 Other events | 0001104659-26-108952 |
| 2026-08-27 | 20:11 ET | [8-K](/filings/0001104659-26-102446.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-102446 |
| 2026-08-18 | 21:29 ET | [10-Q](/filings/0001104659-26-098415.md) | Quarterly report, period 2026-06-30 | 0001104659-26-098415 |
| 2026-08-14 | 23:54 ET | [SCHEDULE 13D/A](/filings/0000899140-26-000895.md) | Ownership report, active investor, amended | 0000899140-26-000895 |
| 2026-08-14 | 12:36 ET | [8-K](/filings/0001104659-26-096510.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-096510 |
| 2026-08-14 | 12:00 ET | [8-K](/filings/0001104659-26-096478.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-096478 |
| 2026-08-12 | 20:01 ET | [8-K](/filings/0001104659-26-094848.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094848 |
| 2026-07-24 | 21:01 ET | [8-K](/filings/0001104659-26-086685.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-086685 |
| 2026-07-24 | 23:54 ET | [8-K](/filings/0001104659-26-086406.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-086406 |
| 2026-07-16 | 20:05 ET | [8-K](/filings/0001104659-26-084242.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-084242 |
| 2026-06-26 | 21:30 ET | [8-K](/filings/0001104659-26-078337.md) | 3.01 Delisting notice | 0001104659-26-078337 |
| 2026-06-16 | 12:46 ET | [8-K](/filings/0001104659-26-074346.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-074346 |
| 2026-06-01 | 01:31 ET | [SCHEDULE 13D/A](/filings/0000899140-26-000621.md) | Ownership report, active investor, amended | 0000899140-26-000621 |
| 2026-06-01 | 21:00 ET | [DEF 14A](/filings/0001140361-26-023583.md) | Proxy statement, period 2026-07-16 | 0001140361-26-023583 |
| 2026-06-01 | 13:15 ET | [8-K](/filings/0001104659-26-068659.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068659 |
| 2026-05-29 | 20:30 ET | [8-K](/filings/0001104659-26-068306.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068306 |
| 2026-05-28 | 21:09 ET | [8-K](/filings/0001104659-26-067614.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-067614 |
| 2026-05-26 | 11:15 ET | [8-K](/filings/0001104659-26-065992.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065992 |
| 2026-05-18 | 23:55 ET | [8-K](/filings/0001104659-26-062865.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-062865 |
| 2026-05-15 | 20:31 ET | [10-Q](/filings/0001104659-26-062632.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062632 |
| 2026-05-13 | 20:36 ET | [8-K](/filings/0001104659-26-060305.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060305 |
| 2026-04-23 | 20:30 ET | [8-K](/filings/0001104659-26-047741.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-047741 |
| 2026-04-21 | 20:15 ET | [8-K](/filings/0001104659-26-046014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046014 |
| 2026-04-07 | 20:15 ET | [8-K](/filings/0001104659-26-040387.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040387 |
| 2026-03-25 | 21:04 ET | [8-K](/filings/0001104659-26-034601.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-034601 |
| 2026-03-16 | 13:00 ET | [8-K](/filings/0001104659-26-028103.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028103 |
| 2026-03-11 | 21:15 ET | [8-K](/filings/0001104659-26-026465.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-026465 |
| 2026-03-10 | 20:30 ET | [8-K](/filings/0001104659-26-025893.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-025893 |
| 2026-03-05 | 22:01 ET | [8-K](/filings/0001104659-26-024189.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-024189 |
| 2026-02-18 | 22:01 ET | [8-K](/filings/0001104659-26-017118.md) | 3.01 Delisting notice | 0001104659-26-017118 |
| 2026-02-17 | 22:01 ET | [10-Q](/filings/0001104659-26-016554.md) | Quarterly report, period 2025-12-31 | 0001104659-26-016554 |
| 2026-02-17 | 13:30 ET | [8-K](/filings/0001104659-26-015887.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-015887 |
| 2026-02-11 | 22:00 ET | [8-K](/filings/0001104659-26-013470.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-013470 |
| 2026-01-26 | 22:01 ET | [DEF 14A](/filings/0001140361-26-002406.md) | Proxy statement, period 2026-03-10 | 0001140361-26-002406 |
| 2026-01-02 | 12:30 ET | [8-K](/filings/0001104659-26-000066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-000066 |
| 2025-12-19 | 22:01 ET | [10-K](/filings/0001104659-25-123264.md) | Annual report, period 2025-09-30 | 0001104659-25-123264 |
| 2025-12-19 | 13:30 ET | [8-K](/filings/0001104659-25-122786.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-122786 |
| 2025-11-13 | 21:15 ET | [8-K](/filings/0001104659-25-111316.md) | 8.01 Other events | 0001104659-25-111316 |
| 2025-11-03 | 22:01 ET | [8-K](/filings/0001104659-25-105633.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105633 |
| 2025-09-29 | 21:00 ET | [8-K](/filings/0001104659-25-094558.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-094558 |
| 2025-09-05 | 21:00 ET | [8-K](/filings/0001104659-25-087886.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-087886 |
| 2025-09-02 | 21:00 ET | [8-K](/filings/0001104659-25-086428.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-086428 |
| 2025-08-14 | 21:00 ET | [10-Q](/filings/0001558370-25-011588.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011588 |
| 2025-08-14 | 20:17 ET | [8-K](/filings/0001104659-25-078622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078622 |
| 2025-07-01 | 20:31 ET | [8-K](/filings/0001104659-25-064755.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-064755 |
| 2025-06-02 | 21:00 ET | [8-K](/filings/0001104659-25-055521.md) | 8.01 Other events | 0001104659-25-055521 |
| 2025-05-28 | 21:24 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000572.md) | Ownership report, active investor, amended | 0000947871-25-000572 |
| 2025-05-23 | 20:22 ET | [8-K](/filings/0001104659-25-052452.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052452 |
| 2025-05-15 | 20:05 ET | [8-K](/filings/0001104659-25-049411.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-049411 |

Page 1 of 6. [Older](/companies/otlk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.